|
US1960170A
(en)
*
|
|
1934-05-22 |
|
Cc - phenylethyl - n - |
|
US2119701A
(en)
|
1934-06-29 |
1938-06-07 |
Winthrop Chem Co Inc |
Alkoxyalkyl mercury nitrogen compounds
|
|
US2673205A
(en)
*
|
1951-02-13 |
1954-03-23 |
Ciba Pharm Prod Inc |
3-disubstituted dioxopiperidines and the manufacture thereof
|
|
DE946804C
(de)
|
1952-02-28 |
1956-08-09 |
Emanuel Merck Ohg |
Verfahren zur Herstellung von schwefelhaltigen Abkoemmlingen der Barbitursaeure
|
|
DE1103339B
(de)
|
1959-02-04 |
1961-03-30 |
Chemische Werke Radebeul Veb |
Verfahren zur Herstellung von in 5-Stellung crotylierten, basisch substituierten Barbitursaeure-derivaten
|
|
DE1100639B
(de)
|
1959-03-24 |
1961-03-02 |
Chemische Werke Radebeul Veb |
Verfahren zur Herstellung von basisch substituierten Barbitursaeure-derivaten
|
|
GB966098A
(en)
|
1959-11-23 |
1964-08-06 |
Sapos Sa |
Barbiturate derivatives
|
|
US3930006A
(en)
|
1963-04-30 |
1975-12-30 |
Aspro Nicholas Ltd |
Antiparkinsonism compositions and method
|
|
US4046894A
(en)
*
|
1968-08-05 |
1977-09-06 |
Bristol-Myers Company |
Certain barbituric acid derivatives used as anticonvulsant agents
|
|
US3679683A
(en)
|
1970-05-11 |
1972-07-25 |
Exxon Research Engineering Co |
Barbiturate 3-n-methylene phosphates
|
|
US3711607A
(en)
*
|
1971-03-17 |
1973-01-16 |
Kendall & Co |
N,n -dihalomethyl phenobarbital for the treatment of convulsions
|
|
US3919427A
(en)
*
|
1972-06-02 |
1975-11-11 |
Kendall & Co |
Therapeutic compositions containing 1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds
|
|
US3904627A
(en)
*
|
1972-06-02 |
1975-09-09 |
Kendall & Co |
1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds
|
|
US3900475A
(en)
*
|
1972-06-26 |
1975-08-19 |
Kendall & Co |
Certain phenobarbital salts
|
|
US3948896A
(en)
*
|
1973-02-28 |
1976-04-06 |
The Kendall Company |
N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same
|
|
US4060528A
(en)
*
|
1975-10-08 |
1977-11-29 |
Janssen Pharmaceutica N.V. |
Aroyl-substituted phenylmalonic acid derivatives
|
|
US4029662A
(en)
*
|
1976-04-30 |
1977-06-14 |
Bristol-Myers Company |
Method of making barbituric acid derivatives
|
|
DE2622981A1
(de)
|
1976-05-21 |
1977-12-08 |
Unisearch Ltd |
Verfahren zur herstellung von halogenalkylierten verbindungen
|
|
US4260769A
(en)
|
1977-04-22 |
1981-04-07 |
Interx Research Corporation |
5,5-Diphenylhydantoins
|
|
EP0103233B1
(en)
*
|
1982-08-31 |
1987-11-25 |
Daikin Kogyo Co., Ltd. |
A method to trap the enolate ion of the malonic acid or its derivatives
|
|
IL69722A
(en)
|
1983-09-14 |
1986-09-30 |
Taro Pharma Ind |
Oxopyrimidine derivatives and pharmaceutical compositions containing them
|
|
US4631294A
(en)
|
1985-07-05 |
1986-12-23 |
University E.M., Inc. |
Treatment of cerebral ischemia with dichloroacetate
|
|
IT1196500B
(it)
*
|
1986-07-16 |
1988-11-16 |
Eniricerche Spa |
Derivati dell'acido malonico e metodi per la loro sintesi
|
|
HU196775B
(en)
*
|
1986-08-05 |
1989-01-30 |
Richter Gedeon Vegyeszet |
Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
|
|
US4833148A
(en)
*
|
1987-04-09 |
1989-05-23 |
Washington University |
Method of using alkenyl- or alkynyl-substituted thiobarbiturates to reduce neurotoxic injury
|
|
US5474990A
(en)
*
|
1989-10-20 |
1995-12-12 |
Olney; John W. |
Barbiturates as safening agents in conjunction with NMDA antagonists
|
|
DE4028040A1
(de)
|
1990-09-05 |
1992-03-12 |
Chemie Linz Deutschland |
Verfahren zur n-alkylierung von harnstoffen
|
|
US5456851A
(en)
|
1994-04-07 |
1995-10-10 |
Johnson & Johnson Consumer Products, Inc. |
Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
|
|
DE4433764A1
(de)
|
1994-09-22 |
1996-03-28 |
Asta Medica Ag |
Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
|
|
DE19504623A1
(de)
|
1995-02-13 |
1996-08-14 |
Bayer Ag |
Verfahren zur Herstellung von N-substituierten cyclischen Imiden
|
|
RU2147584C1
(ru)
*
|
1995-10-27 |
2000-04-20 |
Американ Цианамид Компани |
Способ получения дигалоидазолопиримидинов и способ получения дигидроксиазолопиримидинов
|
|
KR100194535B1
(ko)
*
|
1995-12-27 |
1999-06-15 |
우종일 |
아릴 벤조일 우레아 유도체 및 이를 함유하는 농약조성물
|
|
EP0949259B1
(en)
*
|
1996-12-26 |
2001-06-20 |
Nikken Chemicals Company, Limited |
N-hydroxyurea derivatives and medicinal compositions containing the same
|
|
US5756815A
(en)
*
|
1997-03-18 |
1998-05-26 |
American Cyanamid Company |
Process for the preparation arylamalonates
|
|
US5750766A
(en)
*
|
1997-03-18 |
1998-05-12 |
American Cyanamid Company |
Process for the preparation of arylmalonates
|
|
US6093820A
(en)
*
|
1997-10-02 |
2000-07-25 |
Taro Pharmaceutical Industries Ltd. |
Method and reagents for N-alkylating ureides
|
|
JP2001527083A
(ja)
|
1997-12-31 |
2001-12-25 |
ザ・ユニバーシティ・オブ・カンザス |
第二級および第三級アミン含有薬剤の水溶性プロドラッグおよびその製造方法
|
|
EP1075478B1
(en)
*
|
1998-05-08 |
2003-04-16 |
SmithKline Beecham plc |
Phenylurea and phenylthio urea derivatives
|
|
US7074925B1
(en)
|
1998-05-26 |
2006-07-11 |
Rimma Lliinichna Ashkinazi |
N-substituted derivatives of 5-oxyiminobarbituric acid
|
|
US6156925A
(en)
*
|
1998-09-25 |
2000-12-05 |
American Cyanamid Company |
Process for the preparation of halogenated phenylmaloates
|
|
US7214658B2
(en)
|
2004-07-06 |
2007-05-08 |
Tact Ip, Llc |
Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
|
|
US6262067B1
(en)
*
|
1999-06-22 |
2001-07-17 |
Pfizer Inc. |
Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
|
|
US6281207B1
(en)
|
1999-09-15 |
2001-08-28 |
Reed Richter |
Treatment of movement disorders by administration of mirtazapine
|
|
BR0015974A
(pt)
*
|
1999-12-01 |
2002-07-23 |
Ucb Sa |
Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
|
|
WO2001052823A2
(en)
*
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
|
CA2306170A1
(en)
|
2000-04-18 |
2001-10-18 |
Kenneth Curry |
Novel amino, carboxy derivatives of barbituric acid
|
|
US7683071B2
(en)
|
2000-07-26 |
2010-03-23 |
Taro Pharmaceuticals Industries Ltd. |
Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
|
|
US6756379B2
(en)
*
|
2001-07-26 |
2004-06-29 |
Taro Pharmaceutical Industries Ltd. |
Non-sedating barbiturate compounds as neuroprotective agents
|
|
DE60132337T2
(de)
*
|
2000-07-26 |
2009-02-12 |
Taro Pharmaceutical Industries Ltd. |
Nicht-sedierende barbituratverbindungen als neuroprotektive wirkstoffe
|
|
US6939873B2
(en)
*
|
2000-07-26 |
2005-09-06 |
Taro Pharmaceuticals Industries Limited |
Non-sedating barbituric acid derivatives
|
|
WO2003063872A1
(en)
|
2002-01-30 |
2003-08-07 |
Taro Pharmaceutical Industries Ltd. |
Non-sedating barbituric acid derivatives
|
|
DE60324703D1
(de)
*
|
2002-12-11 |
2008-12-24 |
Taro Pharma Ind |
Barbitursäure derivaten.
|
|
EP1781624A4
(en)
|
2004-07-02 |
2010-06-23 |
Taro Pharma Ind |
PROCESS FOR THE PREPARATION OF 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID
|
|
EP1625848A1
(en)
|
2004-08-10 |
2006-02-15 |
Taro Pharmaceuticals North America, Inc. |
Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid
|
|
EP2081576A4
(en)
|
2006-11-14 |
2010-06-30 |
Taro Pharmaceuticals North Ame |
METHOD FOR IMPROVING BIOAVAILABILITY FOR NON-EDMING BARBITURATES
|